Close Menu

NEW YORK (GenomeWeb) — German molecular diagnostics firm Epigenomics today reported a 21 percent drop in revenues for 2018, resulting from a drop in licensing revenue.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.